MarketPeel
Insider Trading Intelligence
CC

Christine Mikail Cvijic

NGNE
PRESIDENT AND CFO · NEUROGENE INC. · CIK 0001543663
FILING MIX · LIFETIME39%/61%
BUYS
7
SELLS
11
TOTAL VALUE
$1.29M
COMPANIES
1
ACTIVE SINCE
Mar 2024
HOLDINGS NOW
90,370
AVG SELL PX
$26.49
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 27 pending
Forward-return performance of every backtestable P/S trade by Christine Mikail Cvijic, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+77.78%-2.84%-0.05%-2.79%-5.03%
14d9+100.00%-2.38%-0.80%-1.58%-1.14%
30d9+85.71%-6.63%+1.92%-8.18%-13.96%
60d9(2 pending)+0.00%+24.77%+7.63%+16.37%+24.14%
90d9(2 pending)+0.00%+24.89%+9.09%+17.39%+24.40%
180d9(7 pending)+0.00%+0.37%+8.40%-8.03%-8.03%
1y9(7 pending)+0.00%+13.43%+15.92%-2.49%-2.49%
2y9(9 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NGNE · 90,370 shares · as of Jul 2, 2026
032,97565,95098,925131,90020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 7 buys / 11 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
2,531$34.58$87.5K90,370Jul 2, 2026Jul 2, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
1,530$35.23$53.9K88,840Jul 2, 2026Jul 2, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
739$34.06$25.2K92,901Jul 1, 2026Jul 2, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
4,800$32.44$155.7K93,640May 6, 2026May 7, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
4,800$30.07$144.4K98,440May 6, 2026May 7, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
2,558$21.62$55.3K103,240Mar 26, 2026Mar 30, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
1,395$21.25$29.6K106,061Mar 13, 2026Mar 17, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
2,387$20.42$48.7K107,456Mar 13, 2026Mar 17, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
263$22.02$5.8K105,798Mar 13, 2026Mar 17, 2026View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
4,800$25.11$120.5K109,843Feb 27, 2026Mar 3, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
131,900131,900Feb 20, 2026Feb 24, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
22,000114,643Feb 20, 2026Feb 24, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
20,30092,643Mar 26, 2025Mar 28, 2025View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
122,000122,000Mar 26, 2025Mar 28, 2025View →
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
4,501$16.94$76.2K72,343Mar 13, 2025Mar 17, 2025View →
NGNE
NEUROGENE INC.
PURCHASE
President and CFO
24,000$20.48$491.4K76,844Nov 22, 2024Nov 25, 2024View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
53,90053,900Mar 13, 2024Mar 14, 2024View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
31,90352,844Mar 13, 2024Mar 14, 2024View →
Other insiders · NGNE
Loading peer insiders…
About this filer
CIK 0001543663
ROLE
President and CFO
PRIMARY
NGNE
COMPANIES
1
ACTIVE SINCE
Mar 2024
MARKETPEEL · /INSIDER/0001543663DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback